Displaying 10 out of 217 results

  1. FILE PHOTO: A box of VIVITROL medication is photographed in Indiana, Pennsylvania,

    FDA issues warning letter to Alkermes over opioid addiction treatment ad

    A print advertisement of Alkermes Plc's addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated ...
  2. New Content Item

    Correvio Pharma to explore sale after FDA panel setback

  3. New Content Item

    Correvio's heart drug fails to win FDA panel backing

  4. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco

    FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug

    The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, ...
  5. The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel

    US FDA approves generic versions of Novartis blockbuster MS treatment

    The U.S. Food and Drug Administration on Thursday approved three generic versions of Swiss drugmaker Novartis AG's top-selling multiple sclerosis ...
  6. New Content Item

    FDA declines to approve Enzyvant's regenerative tissue therapy

  7. FILE PHOTO: A GSK logo is seen on a flag at a GSK research centre in Stevenage

    GSK seeks FDA approval for investigational HIV treatment

    GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval ...
  8. FILE PHOTO: A sign marks a Biogen facility in Cambridge

    Biogen builds case for its Alzheimer's drug, skeptics say more data needed

    Biogen Inc on Thursday presented new data on its experimental Alzheimer's drug aducanumab that did not reveal any new safety concerns as the U.S.
  9. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche wins FDA approval for immunotherapy cocktail against lung cancer

    Roche's Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker ...